Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)
Clinical trial NCT04621188 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04621188
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-19
- Primary completion
- 2025-02-26
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.